FDA-Approved Medications as Female Viagra

Medications for low sex drive in women are often referred to as "female Viagra." The Food and Drug Administration (FDA) has approved two drugs to address this issue - flibanserin, commonly known as Addyi, and bremelanotide, or Vyleesi.

Description and Application of Flibanserin

Flibanserin, or Addyi, was the first to gain FDA approval in 2015. Initially developed as an antidepressant, it is now repurposed and approved as a treatment for low sexual desire in premenopausal women. This daily pill works on the brain and may boost sex drive in women who find low sexual desire distressing.

Description and Application of Bremelanotide

Bremelanotide, colloquially known as "Female Viagra," is marketed under the brand name Vyleesi.Unlike Addyi, bremelanotide is administered via a self-injection into the belly or thigh.

Enhancing Female Sexual Health and Endurance

In addition to addressing low sexual desire, many women seek ways to enhance their overall sexual experience, including improving stamina and endurance. While medications like Addyi and Vyleesi focus on increasing sexual desire, there are also various products for bed endurance that can help women feel more confident and satisfied during intimate moments. These products, which may include supplements and lifestyle changes, aim to support sexual health and performance, allowing women to enjoy a more fulfilling sexual experience.

This medication is used around 45 minutes before sexual activity.

Target Demographic: Premenopausal Women with Low Sexual Desire

Both Addyi and Vyleesi are designed to treat women suffering from hypoactive sexual desire disorder (HSDD), a condition characterized by low sexual desire. Specifically, they are intended for premenopausal women who experience distress due to this decreased desire.

Comparison of Female Viagra and Male Viagra

While these medications are often dubbed "female Viagra," it's important to note the difference in their workings compared to male Viagra. Viagra works in men by increasing the blood flow to the penis, which helps in achieving an erection. On the other hand, female versions like Addyi and Vyleesi focus on increasing sexual desire and arousal in women, not physical ability.

Unapproved Usage of Viagra for Female Sexual Dysfunction

Despite the hope that Viagra could increase sexual pleasure in women by increasing blood flow to the genital area and aiding orgasm, the FDA has not approved this use of Viagra.

Understanding the Role of Female Viagra

The primary role of the "female Viagra" drugs, Addyi and Vyleesi, is to treat low sexual desire in premenopausal women. However, it's crucial to understand that these are prescription medications with potential side effects. Therefore, before starting any such medication, it's recommended to discuss potential benefits and risks with a healthcare provider. Also, it's worth noting that Addyi takes about four weeks to begin to see an effect, and peak effects aren't seen until eight weeks.